Key Highlights
- Third-quarter sales were USD 692,280, compared with USD 1,514,817.
- Operating expenses dropped to USD 1.6 million from USD 17.2 million.
- Net loss narrowed to USD 2.6 million from USD 33.6 million.
- Loss per share was USD 0.46, against USD 7.82.
A steep fall in operating costs did most of the work at Bonk (NASDAQ:BNKK) in the third quarter of 2026. Total operating expenses came down to USD 1,626,519 from USD 17,215,566, and the net loss narrowed to USD 2,561,225 from USD 33,581,216. The loss per share attributed to common shareholders was USD 0.46, compared with USD 7.82 a year earlier. Net loss attributable to common stockholders came to USD 3,675,603, higher than the net loss owing to preferred stock effects.
Sales were USD 692,280 versus USD 1,514,817, and Gross Profit was USD 1,613 versus USD 543,142. The nine-month gross profit of USD 3,985,708 sits far above the third-quarter figure, pointing to very uneven results across the first nine months.
The Nine Months in Numbers
Over nine months, sales were USD 2,271,548 versus USD 1,601,865, and gross profit was USD 3,985,708 versus USD 588,008. Operating expenses were USD 6,271,700 against USD 26,990,405. The net loss was USD 10,444,540 versus USD 25,533,204, and loss per share was USD 1.45 versus USD 8.83. Net loss attributable to common stockholders for the period was USD 11,558,918. Weighted average shares were about 8.0 million for both the quarter and the nine months.
Marketable securities and Equity securities that were held at year-end no longer appear on the Balance Sheet at September 30. It also booked USD 1,663,936 of common stock issued out of stock payable for services.
How the Company Got Here
The company was previously Safety Shot and, earlier still, Jupiter Wellness. Assets bought in August 2023 included the Sure Shot dietary supplement, which the company calls a blood alcohol reduction drink, and the product reached the market in December 2023. An arrangement agreement with Yerbae Brands Corp. followed in January 2025 and closed on June 27, 2025, bringing Yerbae's beverage subsidiaries into the group. Litigation includes a case brought against Yerbae, LLC.
Preferred stock outstanding was 208,000 shares versus 176,806 at year-end, and related party Revenue sharing assets were USD 1,657,735 versus USD 2,060,968.
Cash, Assets and Equity
Cash fell to USD 90,507 at September 30 from USD 2,278,340 at year-end 2025, a net decrease of USD 2,187,833 over the nine months. Total assets were USD 28,007,691 versus USD 40,973,415.
Digital assets in current assets were USD 3,368,230 versus USD 630,605, inventory was USD 284,018 versus USD 949,275, and a note receivable stood at USD 6,064,379. Non-current digital assets of USD 17,344,636, held at year-end, are no longer carried. Goodwill was USD 14,147,778, and total current liabilities were USD 7,032,828, including a USD 3,000,000 STS Digital loan.
Total shareholders' equity was USD 20,974,863 versus USD 34,996,344, with an accumulated Deficit of USD 193,936,719. Investing activities provided USD 6,607,961 of cash, while financing used USD 3,951,123, which included a USD 4,000,000 Fair Value of treasury stock tied to a Core4 agreement. About 7.94 million common shares were outstanding.
A recovery in sales, the gross profit level after the third-quarter result, control of operating costs and the cash position are the points to follow.






Please wait processing your request...